Literature DB >> 11245510

A primer of complementary and alternative medicine commonly used by cancer patients.

E Ernst1.   

Abstract

Complementary and alternative medicine (CAM) is frequently used by cancer patients, and many oncologists have limited knowledge of CAM. This article provides a brief, evidence-based introduction to several CAM treatments relevant in the context of cancer. "Alternative" diets, chiropractic, coffee enemas, ozone therapy, and shark cartilage seem to have little to offer cancer patients. The evidence for or against homoeopathy and spiritual healing is at present inconclusive. Acupuncture, aromatherapy, and meditation may be useful for nausea/vomiting, for mild relaxation, and for pain/anxiety, respectively. Herbal treatments offer no reasonable prospect of a cure (mistletoe), but could be useful as palliative treatments (eg, for depression [St John's wort] or anxiety [kava]). Our knowledge regarding the potential benefit and harm of CAM is insufficient.

Entities:  

Mesh:

Year:  2001        PMID: 11245510     DOI: 10.5694/j.1326-5377.2001.tb143161.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  3 in total

Review 1.  A primer of complementary and alternative medicine and its relevance in the treatment of mental health problems.

Authors:  Ravinder Mamtani; Andrea Cimino
Journal:  Psychiatr Q       Date:  2002

2.  Shared health characteristics in Hispanic colorectal cancer patients and their primary social support person following primary diagnosis.

Authors:  David S Black; Michael J Li; Ugonna Ihenacho; Nathalie T Nguyen; Maria de Fatima Reyes; Joel Milam; Mary Ann Pentz; Jane C Figueiredo
Journal:  Psychooncology       Date:  2015-08-20       Impact factor: 3.894

3.  Difficulties and perspectives of immunomodulatory therapy with mistletoe lectins and standardized mistletoe extracts in evidence-based medicine.

Authors:  Tibor Hajtó; Krisztina Fodor; Pál Perjési; Pèter Németh
Journal:  Evid Based Complement Alternat Med       Date:  2011-01-09       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.